Abiopharma

🔍 Sajkowski Daniel J (Executive)

Company: Calumet, Inc. /DE (CLMT)

Report Date: 2026-04-01

Detailed Transactions and Holdings:

• Sold 3,310 shares of Common Stock, par value $0.01 per share at $34.46 per share (Direct)
  Date: 2026-04-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 81,958.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025. The closing price of one share of Calumet, Inc. common stock, as reported on the Nasdaq Global Select Market, on the date the Rule 10b5-1 trading plan was adopted by the reporting person was $19.08 per share.
• F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.75 per share to $35.84 per share. The reporting person undertakes to provide to Calumet, Inc., any security holder of Calumet, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.